Andelyn Biosciences

Latest News and Resources

CDMO News

Andelyn Biosciences Manufactures AAV Vector for Upcoming AML Cell Therapy Trial

12 May 2025

CDMO News

Andelyn Biosciences Expands AAV Curator Platform with Broad Institute Agreement

19 February 2025

CDMO News

Andelyn Biosciences to Manufacture AAV for Hubble Therapeutics’ LCA16 Gene Therapy

10 October 2024

CDMO News

Andelyn Biosciences Licenses MyoAAV Plasmids from Broad Institute

7 August 2024

CDMO News

Andelyn Biosciences Partners with UMass for Cockayne Syndrome Gene Therapy Trials

11 July 2024

CDMO News

Andelyn Biosciences Partners with Grace to Manufacture GS-100 for NGLY1 Gene Therapy

26 March 2024